Search
Search
Close this search box.

Europe’s Smaller Hemp Farms Face a ‘Grim Outlook’ For 2022, Finds Survey

HIGHER energy costs, staff shortages and Covid-induced supply chain issues have left Europe’s hemp farmers feeling the pinch, finds a new market report.

The CanXChange Q4 Benchmark Report finds many of the continent’s small farms are facing a ‘grim outlook’ for 2022, due to high stock levels and ‘fairly low confidence in sales prospects’. 

However, the report also highlights how Europe’s larger producers remain bullish with the positive sentiment up 20% on Q3.

Discussing the vagaries between larger and smaller players the report authors speculate ‘while we we anticipate a global demand increase for cannabis based products…the whole market spectrum may not develop at the same pace or benefit from the same growth opportunities. 

Spot Market Blues

‘Unfortunately, we tend to think that this sentiment difference between smaller and bigger production units will remain (exceptions obviously exist)’.

They go on to highlight three key differences between larger and smaller players which include; a lower exposure to the spot market, greater product diversification which in turn delivers on the potential to tap an into an increased number of market segments.

 CanXChange is a physical commodity exchange and wholesale data provider for industrial hemp and its many derivatives including; shives, fibres, CBD and seeds.

This quarter’s benchmark report takes a detailed look at various cannabinoid market segments including CBD, CBG and CBN.

It finds that after several months of stable prices increased competition in the the CBD isolate market is seeing prices fall from €400-€500 per kg down to the to the mid €300’s per kg on orders above 25kg. 

It says: “It seems that the oversupply is still abundant and the downward price pressure has not given way just yet. We do expect this trend to continue into the year end and it could exert some more pressure pushing prices to the low 300’s on larger orders.”

However, the authors believe this will flush out some smaller players with prices set to rise to over €500 in due course.

In assembling its quarterly reports CanXChange’s research team have spent weeks surveying over 100 hemp farms and cooperatives across Europe. 

Five Key Metrics

And it has developed five key metrics to better understand the outlook for cultivation activity. These include:

-Surfaces planted compared to the previous season 

-Increase/decrease of production investments 

-Stock levels

-Sales confidence

-Cultivation yields 

After then overlaying this with farm size it produces separate charts demonstrating confidence levels for facilities of less than 500 hectares, those between 500 and 1,000ha and those over 1,000ha.

The report finds that those farming less than 500ha are less confident than in the previous quarter and those above 500ha more confident.

It adds: “Overall we can see that the farms surveyed are fairly optimistic… but the sentiment is shifting down compared to the July ‘21 Index. This slight shift of sentiment towards the south is explained by global degraded conditions (energy, logistics and labour costs and/or shortage)…with small production units (less than 500 ha) suffering the most from this situation.”

The exchange has hundreds of fully-vetted customers with clients in over 25 countries and over €50m of trade-able inventory from Europe, the US and South America.

To view the report click here

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?